Martin D. Johnson

Placeholder Person Graphic
Eli Lilly and Co
Vice President of Engineering
Martin D. Johnson is Vice President of Engineering at Eli Lilly and Company in synthetic molecule design and development. Martin’s group has used continuous reactions in the manufacture of APIs for highly exothermic and hazardous reactions, high pressure reactions with hazardous gas reagent like hydrogenations, chemistries at extreme temperatures and pressures, and process separations including distillation, extraction, crystallization, and filtration. He received the 2016 ACS Award for Affordable Green Chemistry, the 2016 AIChE Award for Outstanding Contribution to QbD, and the 2021 AIChE Practice Award in the Catalysis and Reaction Engineering Division. He received his dual doctorate in chemical engineering and environmental engineering from the University of Michigan in 2000 and his undergraduate in chemical engineering from Virginia Tech.

Related Articles

Continuous Manufacturing of Small Molecule Drug Substances
Online Exclusives
Continuous Manufacturing of Small Molecule Drug Substances

The adoption of continuous manufacturing (CM) in the pharmaceutical industry is increasing because of the advantages and opportunities it offers, including the ability to handle hazardous reactions, a higher degree of process integration, and improved sustainability. This article discusses the considerations and approaches adopted by Pfizer, Eli Lilly, GSK, and Amgen in designing and...